CMWAY Financial Statements & Analysis
Complete financial statements for CMWAY including income statement, balance sheet, and cash flow statement. Analyze CMWAY's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
167.0% ↑
Net Income
7.7% ↑
Gross Margin
-60.7% ↓
Operating Margin
-64.3% ↓
Balance Sheet
Current Ratio
12.7% ↑
Debt to Equity
47.4% ↓
Asset Turnover
147.4% ↑
Cash Flow
Operating Cash Flow
98.3% ↑
Net Cash Flow
111.8% ↑
Free Cash Flow
94.9% ↑
Cash Flow to Debt
98.9% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 26.12B | 69.74B | 167.0% | |
| Gross Profit | 27.31B | 28.66B | 4.9% | |
| Operating Income | 15.24B | 14.55B | 4.6% | |
| Net Income | 9.39B | 10.12B | 7.7% | |
| EPS | 5.68 | 6.05 | 6.5% | |
| EBITDA | 15.28B | 15.95B | 4.4% | |
| Gross Margin | 104.56% | 41.09% | 60.7% | |
| Operating Margin | 58.36% | 20.86% | 64.3% | |
| Net Income Margin | 35.97% | 14.50% | 59.7% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 69.74B | 26.12B | 26.33B | — | — |
| Gross Profit | 28.66B | 27.31B | 27.07B | — | — |
| Operating Income | 14.55B | 15.24B | 15.69B | — | — |
| Net Income | 10.12B | 9.39B | 10.00B | — | — |
| EPS | 6.05 | 5.68 | 5.97 | — | — |
| EBITDA | 15.95B | 15.28B | 15.41B | — | — |
| Gross Margin | 41.09% | 104.56% | 102.83% | — | — |
| Operating Margin | 20.86% | 58.36% | 59.61% | — | — |
| Net Income Margin | 14.50% | 35.97% | 37.98% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into CMWAY's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics